van Oijen M G, Medema R H, Slootweg P J, Rijksen G
Department of Haematology, Jordan Laboratory, University Hospital Utrecht, The Netherlands.
Am J Clin Pathol. 1998 Jul;110(1):24-31. doi: 10.1093/ajcp/110.1.24.
Ki-67 is a proliferation marker that is often used to estimate the growth fraction of tumors and other tissues. This antigen is expressed during all phases of the cell cycle but not in quiescent G0 cells. Many studies fail to indicate that the Ki-67 antigen can be expressed even when DNA synthesis is blocked. We studied the expression of the antigen Ki-67 in cycle-arrested osteosarcoma cells. We found that these cells are positive for Ki-67 even when they are arrested in G1/S or G2/M by using synchronizing inhibitors, by inducing p21(Waf1/Cip1) in a tetracycline-regulated expression system or by inducing wild type p53 and p21 after inflicting DNA damage. Our results show that not all cells containing the Ki-67 antigen are actively proliferating cells and we advise against the use of Ki-67 in studies on cells that overexpress p53 or p21.
Ki-67是一种增殖标志物,常用于评估肿瘤及其他组织的生长分数。该抗原在细胞周期的所有阶段均有表达,但静止的G0期细胞中不表达。许多研究未能指出,即便DNA合成受阻,Ki-67抗原仍可表达。我们研究了细胞周期阻滞的骨肉瘤细胞中Ki-67抗原的表达情况。我们发现,通过使用同步化抑制剂使细胞阻滞于G1/S期或G2/M期,在四环素调控表达系统中诱导p21(Waf1/Cip1),或在造成DNA损伤后诱导野生型p53和p21,这些细胞的Ki-67均呈阳性。我们的结果表明,并非所有含有Ki-67抗原的细胞都是活跃增殖细胞,我们建议在对p53或p21过表达的细胞进行研究时不要使用Ki-67。